1. Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study

   • T. M. Loeffler
   • F. W. Weber
   • T. U. Hausamen

   OriginalPaper Pages: S125 - S128

2. Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility

   • T. Cerny
   • A. Graf
   • A. Küpfer

   OriginalPaper Pages: S129 - S134

3. Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study

   • T. Cerny
   • G. Martinelli
   • A. Küpfer

   OriginalPaper Pages: S135 - S138

4. A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer

   • H. Anderson
   • J. Prendiville
   • R. Swindell

   OriginalPaper Pages: S139 - S140

5. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients

   • Rolf D. Issels
   • Johann Mittermüller
   • Wolfgang Wilmanns

   OriginalPaper Pages: S141 - S147

6. Metabolism and pharmacokinetics of oral and intravenous ifosfamide

   • V. Kurowski
   • T. Cerny
   • T. Wagner

   OriginalPaper Pages: S148 - S153

7. The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump

   • J. A. Radford
   • J. M. Margison
   • N. Thatcher

   OriginalPaper Pages: S154 - S156

8. In vitro studies on drug interaction of ifosfamide and ACNU in primary and metastatic human brain tumours

   • Ulrich Bogdahn
   • Daniela Drenkard
   • Christian Behl

   OriginalPaper Pages: S157 - S163

9. Dosing and side-effects of ifosfamide plus mesna

   • W. P. Brade
   • K. Herdrich
   • C. E. Araujo

   OriginalPaper Pages: S164 - S186

10. Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines

    • M. Wolf
    • M. Maasberg
    • K. Havemann

    OriginalPaper Pages: S187 - S192

11. Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group

    • W. P. Steward
    • J. Verweij
    • K. Kelly

    OriginalPaper Pages: S193 - S197

12. Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma

    • A. Harstrick
    • H. -J. Schmoll
    • H. Poliwoda

    OriginalPaper Pages: S198 - S202

13. Effect of rhGM-CSF on haematopoietic reconstitution after chemotherapy in small-cell lung cancer

    • K. Havemann
    • M. Klausmann
    • W. Oster

    OriginalPaper Pages: S203 - S207

14. Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study

    • Anthony D. Elias
    • Lois J. Ayash
    • Karen H. Antman

    OriginalPaper Pages: S208 - S213

15. Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer

    • H. O. Klein
    • G. Golbach
    • C. Bernhardt

    OriginalPaper Pages: S214 - S220

16. Ifosfamide, vindesine and recombinant α-interferon combination chemotherapy for metastatic renal cell carcinoma

    • H. J. König
    • W. Gutmann
    • J. Weissmüller

    OriginalPaper Pages: S221 - S223

17. Ifosfamide and ACNU in experimental allogeneic bone marrow transplantation

    • W. Gassmann
    • A. Erbersdobler
    • W. Mueller-Ruchholtz

    OriginalPaper Pages: S224 - S227

18. Ifosfamide in tumour therapy: questions for the Nineties

    Satellite Symposium Pages: S228 - S231